These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Johnson & Johnson (JNJ) Stock Moves -0.03%: What You Should Know

Johnson & Johnson (JNJ) Stock Moves -0.03%: What You Should Know

Investors hope GE spinoff will defy poor track record of breakups

US takes next step in Medicare drug price negotiations with pharma companies

AI ETFs: Q1 of 2024 Update

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

25 Things Every Dividend Investor Should Know

Microsoft, Salesforce woo skeptical CFOs on new generative AI tool spending

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week

Declining Stock and Decent Financials: Is The Market Wrong About Johnson & Johnson (NYSE:JNJ)?

Convincing Religious Groups to Get Measles Shots

Shockwave Medical (SWAV) Up on Potential Acquisition Rumors

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

Kodak’s Pension Windfall Points to a $137 Billion Opportunity

J&J to Pay $75 Million to Settle Mississippi’s Baby Powder Suit

4 Best ETF Areas of Q1

UPDATE 3-J&J can contest evidence linking its talc to cancer, US judge rules